GO:0042824 MHC class I peptide loading complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042824 describes the MHC class I peptide loading complex (PLC), a large multisubunit assembly in the endoplasmic reticulum that loads antigenic peptides onto MHC class I molecules [1, 2].
• The PLC contains the MHC class I heavy chain–beta 2 microglobulin dimer, the transporter associated with antigen presentation (TAP), tapasin, calreticulin, and the thiol oxidoreductase ERp57 [1, 4].
• Tapasin acts as the keystone of the PLC, bridging MHC class I to TAP and optimizing peptide selection and exchange.
• The PLC is a target of viral immune evasion proteins that inhibit TAP and block antigen presentation.
• Defects in PLC components reduce cell-surface MHC class I presentation and impair CD8+ T cell responses, with implications for cancer and infectious disease [2, 6].
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of PLC gene function in antigen presentation [5, 8].
Description
The MHC class I peptide loading complex (PLC) is a multisubunit cellular machine that assembles peptides with newly synthesized MHC class I molecules in the endoplasmic reticulum (ER). This complex is essential for the presentation of intracellular antigens to CD8+ T cells and therefore sits at the heart of adaptive immunity. The PLC coordinates peptide translocation by TAP, peptide editing by tapasin, and chaperone-assisted folding of MHC class I [4, 7]. Because the PLC determines which peptides reach the cell surface, its components are intensively studied in cancer immunology, virology, and vaccine design [3, 6]. Researchers use the GO term GO:0042824 to annotate proteins and complexes that function in this assembly pathway. Understanding the PLC at molecular resolution provides a framework for therapeutic manipulation of antigen presentation.
MHC class I peptide loading complex At A Glance
| GO ID | GO:0042824 |
|---|---|
| GO term | MHC class I peptide loading complex |
| Ontology | cellular_component |
| Synonym | peptide-loading complex, PLC |
| Major function | Assembly of peptides with newly synthesized MHC class I molecules |
| Key components | MHC class I heavy chain, beta 2 microglobulin, TAP, tapasin, calreticulin, ERp57 |
| Subcellular location | Endoplasmic reticulum membrane |
| Related process | Antigen processing and presentation via MHC class I |
What Is GO:0042824?
GO:0042824 (MHC class I peptide loading complex) is a cellular component term describing a large, multisubunit complex composed of the MHC class I–beta 2 microglobulin dimer, the transporter associated with antigen presentation (TAP), tapasin, the chaperone calreticulin, and the thiol oxidoreductase ERp57 [1, 4]. This complex functions in the assembly of peptides with newly synthesized MHC class I molecules in the endoplasmic reticulum. The synonym peptide-loading complex (PLC) is commonly used in the literature.
Why Is MHC class I peptide loading complex Important in Cell Biology?
The PLC is the central quality-control checkpoint that determines which peptides are loaded onto MHC class I molecules and displayed to CD8+ T cells [1, 7]. Its activity shapes the repertoire of antigens recognized by cytotoxic T lymphocytes, making it critical for antiviral and antitumor immunity [2, 3]. Many viruses encode proteins that specifically target PLC components, especially TAP and tapasin, to evade immune detection. In cancer, loss or downregulation of PLC genes contributes to immune escape and resistance to checkpoint blockade. Consequently, the PLC is a high-value subject for basic immunology and translational research.
• Controls the peptide repertoire presented by MHC class I to CD8+ T cells.
• Essential for adaptive immunity against intracellular pathogens and tumors.
• Targeted by viral immune evasion proteins that inhibit TAP.
• Tapasin within the PLC optimizes peptide binding and exchange.
• Defects in PLC components cause impaired antigen presentation and immune escape.
• Provides a model for studying ER chaperone networks and redox regulation.
• Enables structure-function studies of a large membrane-associated complex.
• Supports development of vaccines and immunotherapies that enhance antigen presentation.
• Links ER quality control to cell-surface immune surveillance.
• Offers CRISPR-tractable targets for modulating antigen presentation.
Structure and Composition of MHC class I peptide loading complex
MHC class I heavy chain and beta 2 microglobulin
In simple terms: The MHC class I molecule is the cargo that receives a peptide.
The PLC contains the MHC class I heavy chain bound to beta 2 microglobulin as a heterodimer. This dimer is the substrate for peptide loading and is retained in the ER until a suitable peptide is acquired. The peptide-binding groove of the heavy chain is stabilized by beta 2 microglobulin, and chaperones within the PLC facilitate its folding and peptide acquisition.
Transporter associated with antigen presentation (TAP)
In simple terms: TAP is the pump that brings peptides into the ER.
TAP is a heterodimeric ABC transporter embedded in the ER membrane that translocates cytosolic peptides into the ER lumen. Within the PLC, TAP delivers peptides directly to the MHC class I–tapasin module. TAP is a frequent target of viral inhibitors that block peptide supply to the PLC.
Tapasin
In simple terms: Tapasin is the bridge that connects MHC class I to TAP.
Tapasin is an MHC-encoded membrane protein that serves as the keystone of the PLC, bridging MHC class I to TAP and stabilizing the peptide-receptive state of MHC class I. Tapasin also functions as a peptide editor, promoting the exchange of low-affinity peptides for high-affinity ones. Its presence is required for optimal peptide loading and for the stability of the PLC.
Calreticulin and ERp57
In simple terms: Calreticulin and ERp57 are helper proteins that assist folding and redox chemistry.
Calreticulin is a lectin-like chaperone that binds monoglucosylated N-glycans on MHC class I and facilitates its folding within the PLC. ERp57 is a thiol oxidoreductase that interacts with calreticulin and tapasin and contributes to disulfide bond formation and quality control in the complex. Together, these chaperones and oxidoreductases ensure proper assembly and peptide loading.
Assembly and stoichiometry of the PLC
In simple terms: The PLC is built step by step in the ER membrane.
The PLC assembles in the ER membrane through sequential interactions among TAP, tapasin, MHC class I, calreticulin, and ERp57. The complex is a large multisubunit assembly whose stoichiometry and dynamic organization have been studied by biochemical and structural methods. Assembly is coordinated with the peptide translocation cycle, and the complex disassembles after stable peptide loading and ER exit of MHC class I.
Key Genes Involved in GO:0042824 MHC class I peptide loading complex
The following genes and proteins are core components or regulators of the MHC class I peptide loading complex (GO:0042824).
| Gene | Major Role | Research Relevance |
|---|---|---|
| HLA-A | MHC class I heavy chain that presents peptides to CD8+ T cells | Central cargo of the PLC; target for knockout and knock-in studies |
| HLA-B | MHC class I heavy chain with broad peptide repertoire | Determines antigen presentation breadth; disease associations |
| HLA-C | MHC class I heavy chain recognized by NK cells | Links PLC function to NK cell education |
| B2M | Beta 2 microglobulin, light chain of MHC class I | Frequently mutated in tumors with antigen presentation defects |
| TAP1 | Subunit of the TAP peptide transporter | Essential for peptide supply to the PLC; viral target |
| TAP2 | Subunit of the TAP peptide transporter | Required for peptide translocation; knockout impairs presentation |
| TAPBP | Tapasin, keystone of the PLC | Bridges MHC class I and TAP; peptide editing function |
| CALR | Calreticulin chaperone | Assists MHC class I folding in the PLC |
| PDIA3 | ERp57 thiol oxidoreductase | Redox regulation of PLC assembly |
| CANX | Calnexin chaperone | Early MHC class I folding before PLC entry |
| HSPA5 | BiP chaperone in the ER | General ER quality control affecting PLC assembly |
| SEC61A1 | ER translocon subunit | Coordinates synthesis of PLC components |
| ERAP1 | ER aminopeptidase trimming peptides | Shapes peptide repertoire loaded by the PLC |
| ERAP2 | ER aminopeptidase trimming peptides | Modifies peptide supply to the PLC |
| NLRC5 | Transcriptional regulator of MHC class I genes | Controls expression of PLC components |
| PSMB8 | Immunoproteasome subunit | Generates peptides for TAP and the PLC |
| PSMB9 | Immunoproteasome subunit | Supports peptide supply to the PLC |
How Is MHC class I peptide loading complex Regulated?
The PLC is regulated at multiple levels. Transcription of MHC class I heavy chain, TAP, and tapasin genes is controlled by the NLR family member NLRC5, which coordinates expression of antigen presentation machinery. Peptide supply to the PLC is regulated by the immunoproteasome and ER aminopeptidases ERAP1 and ERAP2, which trim peptides to optimal length for TAP translocation and MHC class I binding [2, 5]. Viral proteins can inhibit TAP and disrupt the PLC, representing a pathogen-driven regulatory mechanism. Redox conditions in the ER influence ERp57 activity and disulfide bond formation within the PLC. Additionally, the PLC is dynamically assembled and disassembled in coordination with the peptide loading cycle.
MHC class I peptide loading complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| B2M | Tumor immune escape and checkpoint blockade resistance | B2M knockout cancer cell lines |
| TAP1 | Impaired antigen presentation and viral evasion | TAP1 knockout or point-mutation models |
| TAPBP | Defective peptide editing and immune escape | Tapasin knockout and knock-in cell lines |
| ERAP1 | Autoimmune disease and peptide repertoire alteration | ERAP1 point-mutation knock-in models |
| NLRC5 | Loss of MHC class I expression in cancer | NLRC5 knockout and overexpression models |
Cancer immune evasion
Tumors frequently downregulate or mutate components of the MHC class I peptide loading complex, including B2M, TAP1, TAP2, and tapasin, leading to defective antigen presentation and escape from CD8+ T cell surveillance. Loss of B2M is a well-documented mechanism of resistance to immune checkpoint blockade. Restoring PLC function is therefore a therapeutic goal in immuno-oncology.
Viral immune evasion
Many viruses encode proteins that specifically inhibit TAP or tapasin, thereby blocking peptide loading onto MHC class I and preventing recognition by cytotoxic T lymphocytes. These viral inhibitors have been instrumental in dissecting PLC structure and function. Understanding these mechanisms informs antiviral strategies and vaccine design.
Autoimmunity and inflammatory disease
Polymorphisms in MHC class I genes and in ERAP1/ERAP2, which shape the peptide repertoire loaded by the PLC, are associated with autoimmune conditions such as ankylosing spondylitis and Behçet's disease. Altered peptide loading can contribute to autoantigen presentation. The PLC is thus relevant to both tolerance and autoimmunity.
From MHC class I peptide loading complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TAP1 abolish peptide loading onto MHC class I? | TAP1 knockout cell line |
| Does a specific tapasin point mutation impair peptide editing? | Tapasin point-mutation knock-in |
| Can tagged tapasin be used to isolate the PLC? | Tagged knock-in of TAPBP |
| Does overexpression of NLRC5 enhance antigen presentation? | NLRC5 overexpression cell model |
| Does B2M loss confer resistance to T cell killing? | B2M knockout tumor model |
| Can ERAP1 trimming be modulated to alter the peptide repertoire? | ERAP1 knockout or point-mutation models |
How to Study the MHC class I peptide loading complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunoprecipitation | PLC subunit composition | Isolation of tapasin–TAP–MHC class I complexes |
| Mass spectrometry | Protein interactions and modifications | Interactome mapping of the PLC |
| Flow cytometry | Cell-surface MHC class I expression | Phenotyping of PLC gene knockouts |
| In vitro peptide loading assay | Peptide binding and exchange | Functional analysis of tapasin and TAP |
| Cryo-EM | Three-dimensional structure | Structural dissection of TAP and PLC |
| Fluorescence microscopy | Subcellular localization and assembly | Visualizing PLC dynamics in the ER |
| CRISPR screening | Gene requirements for antigen presentation | Identifying novel PLC regulators |
| RNA-seq | Transcriptional profiling of PLC genes | Assessing NLRC5-dependent expression |
Biochemical isolation of the PLC
The PLC can be isolated from cell lysates using antibodies against tapasin, TAP, or tagged MHC class I, followed by immunoprecipitation and mass spectrometry. These approaches define the subunit composition and stoichiometry of the complex. In vitro peptide loading assays using purified components allow direct measurement of peptide exchange.
Flow cytometry and immunodetection
Cell-surface MHC class I levels are routinely measured by flow cytometry using conformation-specific antibodies, providing a readout of PLC function. Intracellular staining for tapasin, TAP, and calreticulin can assess expression and assembly. These methods are widely used to evaluate knockout and knock-in phenotypes.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry identifies PLC-associated proteins and post-translational modifications. Quantitative proteomics can compare PLC composition between wild-type and mutant cells. These techniques reveal dynamic changes in the complex under different physiological conditions.
Structural and imaging approaches
Cryo-electron microscopy and X-ray crystallography have provided structural insights into TAP and tapasin organization within the PLC. Fluorescence microscopy and FRET can visualize PLC assembly in living cells. These methods complement biochemical and genetic studies.
How CRISPR Can Be Used to Study GO:0042824 MHC class I peptide loading complex
Knockout
CRISPR knockout of PLC genes such as TAP1, TAP2, TAPBP, B2M, CALR, or PDIA3 abolishes or severely impairs peptide loading and cell-surface MHC class I presentation [2, 6]. These models are used to test the requirement of each component for antigen presentation and immune recognition. Knockout cell lines also serve as negative controls in peptide loading assays.
Point Mutation
Point mutations introduced into tapasin, TAP, or MHC class I genes allow structure-function analysis of specific residues involved in peptide editing, TAP binding, or redox regulation. Such models can separate peptide transport from peptide editing functions. They are valuable for dissecting the molecular mechanism of the PLC.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous PLC genes enables affinity purification and live-cell imaging of the complex. Tagged tapasin or TAP knock-in lines facilitate proteomic and dynamic studies. Knock-in of disease-associated variants can model altered antigen presentation.
Overexpression
Overexpression of PLC components such as NLRC5, tapasin, or TAP can enhance antigen presentation and boost CD8+ T cell responses. These models are used to test whether increasing PLC activity overcomes immune evasion. Overexpression combined with knockout provides bidirectional control of PLC function.
How EDITGENE Supports MHC class I peptide loading complex Research
Researchers studying MHC class I peptide loading complex-related genes often need to determine whether a candidate gene is causally involved in antigen presentation, immune evasion, or autoimmunity. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible interrogation of PLC gene function.
Contact EDITGENE today to design your custom CRISPR model for MHC class I peptide loading complex research.
Frequently Asked Questions About MHC class I peptide loading complex
What is the MHC class I peptide loading complex?
The MHC class I peptide loading complex (GO:0042824) is a large multisubunit assembly in the endoplasmic reticulum that loads antigenic peptides onto MHC class I molecules for presentation to CD8+ T cells [1, 2].
What genes are involved in the MHC class I peptide loading complex?
Core genes include HLA-A, HLA-B, HLA-C, B2M, TAP1, TAP2, TAPBP (tapasin), CALR, and PDIA3 (ERp57) [1, 4].
What is the function of tapasin in the peptide loading complex?
Tapasin is the keystone of the PLC, bridging MHC class I to TAP and acting as a peptide editor that selects high-affinity peptides.
How does TAP contribute to MHC class I peptide loading?
TAP is an ABC transporter that translocates cytosolic peptides into the ER, supplying the PLC with peptide cargo.
What is the role of ERp57 in the PLC?
ERp57 is a thiol oxidoreductase that interacts with calreticulin and tapasin and contributes to disulfide bond formation and quality control in the PLC.
How do viruses evade the MHC class I peptide loading complex?
Many viruses encode proteins that inhibit TAP or tapasin, blocking peptide loading and preventing CD8+ T cell recognition.
What diseases are linked to defects in the peptide loading complex?
Defects in PLC components are linked to cancer immune evasion, viral immune evasion, and autoimmune conditions such as ankylosing spondylitis [5, 6].
How can CRISPR be used to study the MHC class I peptide loading complex?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal dissection of PLC gene function in antigen presentation [5, 8].
What methods are used to study the peptide loading complex?
Common methods include immunoprecipitation, mass spectrometry, flow cytometry, in vitro peptide loading assays, cryo-EM, and CRISPR screens [1, 3, 5].
Why is the MHC class I peptide loading complex important for immunotherapy?
Because it determines which antigens are presented to T cells, the PLC influences tumor immune escape and responses to checkpoint blockade.
Conclusion
The MHC class I peptide loading complex (GO:0042824) is a central machine of adaptive immunity that assembles peptides with MHC class I molecules in the endoplasmic reticulum [1, 2]. Its components, including TAP, tapasin, calreticulin, and ERp57, are essential for antigen presentation and are frequently targeted by viruses and tumors [3, 6]. Continued research using CRISPR models and advanced proteomic and structural methods will clarify how the PLC can be manipulated for therapeutic benefit.
References
- 1. Cresswell P et al.. 1999. The nature of the MHC class I peptide loading complex.. Immunol Rev 172:21-8 PMID: 10631934
- 2. Schölz C et al.. 2009. The peptide-loading complex--antigen translocation and MHC class I loading.. Biol Chem 390(8):783-94 PMID: 19426129
- 3. Praest P et al.. 2019. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins.. Mol Immunol 113:103-114 PMID: 29606337
- 4. Koch J et al.. 2006. The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation.. Cell Mol Life Sci 63(6):653-62 PMID: 16465444
- 5. Bouvier M. 2019. In Vitro Studies of MHC Class I Peptide Loading and Exchange.. Methods Mol Biol 1988:71-81 PMID: 31147933
- 6. Wright CA et al.. 2004. Tapasin and other chaperones: models of the MHC class I loading complex.. Biol Chem 385(9):763-78 PMID: 15493870
- 7. Momburg F et al.. 2002. Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum.. Mol Immunol 39(3-4):217-33 PMID: 12200052
- 8. Grommé M et al.. 1999. Recycling MHC class I molecules and endosomal peptide loading.. Proc Natl Acad Sci U S A 96(18):10326-31 PMID: 10468607
